EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

The TET3/GATA6 Axis Drives Lipid Metabolism and Therapeutic Vulnerabilities in Pancreatic Ductal Adenocarcinoma

Shuai Liu, Shaobo Kang, Na Lin, Wenqi Zhang, Shiwen Wang, Yuqing Ren, Xiaofan Ding, Jianxiu Yu iD, Ruiyu Xie iD

Advanced Science · 2025-10 · 12 (37)

DOI: 10.1002/advs.202501774 ↗

At a glance

Journal article in Advanced Science, published online on 2025-06-26. Written by Shuai Liu and 8 co-authors. Institution: Department of Biomedical Sciences, Faculty of Health Sciences, University of Macau, Macau SAR, 999078, China. Major MEDLINE topics: Carcinoma, Pancreatic Ductal, Lipid Metabolism, GATA6 Transcription Factor, Pancreatic Neoplasms. Cited 14 times so far (Crossref); 82 references. The full text is freely available (open access, CC BY 4.0). Funded by: Fundo para o Desenvolvimento das Ciências e da Tecnologia, National Natural Science Foundation of China, Universidade de Macau.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Metabolic reprogramming is a hallmark of cancer, with dysregulated lipid metabolism contributing to tumor progression and therapy resistance. This study identifies the DNA demethylase TET3 as a key regulator of lipogenic metabolism in pancreatic ductal adenocarcinoma (PDAC). TET3 expression is elevated in the lipogenic PDAC subtype and correlates with poor patient prognosis. Genetic ablation of TET3 disrupts lipid homeostasis, alters the saturated‐to‐monounsaturated fatty acid ratio, and reduces proliferative capacity. Mechanistically, TET3 represses GATA6 expression through recruitment of histone deacetylases (HDACs) to its promoter, leading to H3K27 deacetylation, independent of its catalytic activity. Loss of TET3 derepresses GATA6 , which in turn suppresses lipogenic enzymes, such as stearoyl‐CoA desaturase ( SCD ) and acyl‐CoA synthetase long‐chain family member 3 ( ACSL3 ), and sensitizes cells to ferroptosis. Notably, combined treatment with the HDAC inhibitor SAHA and the ferroptosis inducer Erastin significantly enhances gemcitabine‐induced cytotoxicity in lipogenic PDAC cells. These findings uncover a previously unrecognized non‐catalytic function of TET3 in sustaining lipid metabolic reprogramming in PDAC. Targeting the TET3/GATA6 axis in combination with ferroptosis and epigenetic modulators offers a promising strategy to overcome therapeutic resistance in aggressive pancreatic cancer.

Subjects

MeSH terms (MEDLINE)

Carcinoma, Pancreatic DuctalLipid MetabolismGATA6 Transcription FactorPancreatic NeoplasmsDioxygenasesHumansCell Line, TumorAnimalsMiceGene Expression Regulation, Neoplastic

Author keywords

GATA6TET3epigenetic regulationlipid metabolic reprogrammingpancreatic ductal adenocarcinoma

Substances

GATA6 Transcription FactorGATA6 protein, humanDioxygenases

Authors and institutions

  • Department of Biomedical Sciences, Faculty of Health Sciences, University of Macau, Macau SAR, 999078, China.
  • Ministry of Education Frontiers Science Center for Precision Oncology, University of Macau, Macau SAR, 999078, China.
  • Department of Biochemistry and Molecular Cell Biology & Shanghai Key Laboratory of Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.

ORCID profiles: Jianxiu Yu, Ruiyu Xie

Funding

  • Fundo para o Desenvolvimento das Ciências e da Tecnologia
  • National Natural Science Foundation of China
  • Universidade de Macau

Cite

APA

Liu, S., Kang, S., Lin, N., Zhang, W., Wang, S., Ren, Y., Ding, X., Yu, J., & Xie, R. (2025). The TET3/GATA6 Axis Drives Lipid Metabolism and Therapeutic Vulnerabilities in Pancreatic Ductal Adenocarcinoma. Advanced Science, 12(37). https://doi.org/10.1002/advs.202501774

Vancouver

Liu S, Kang S, Lin N, Zhang W, Wang S, Ren Y, et al. The TET3/GATA6 Axis Drives Lipid Metabolism and Therapeutic Vulnerabilities in Pancreatic Ductal Adenocarcinoma. Advanced Science. 2025;12(37). doi:10.1002/advs.202501774

BibTeX
@article{Liu2025,
  author = {Liu, Shuai and Kang, Shaobo and Lin, Na and Zhang, Wenqi and Wang, Shiwen and Ren, Yuqing and Ding, Xiaofan and Yu, Jianxiu and Xie, Ruiyu},
  title = {The TET3/GATA6 Axis Drives Lipid Metabolism and Therapeutic Vulnerabilities in Pancreatic Ductal Adenocarcinoma},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {37},
  doi = {10.1002/advs.202501774}
}
Start for free →